Event Details

2021 ASTRO Annual Meeting

Oct 24 2021

At this year’s American Society of Radiation Oncology (ASTRO) Annual Meeting, Nanobiotix will be providing updated data from its phase I head and neck cancer and phase I immunotherapy study. The conference will be a live event held at McCormick Place West in Chicago from October 24th to 27th . To complement the meeting, the Digital XP platform is available for virtual attendees with curated content available from October 23rd to November 30th.

ASTRO is the largest and most influential meeting for the radiation oncology community. Founded in 1958, ASTRO is the premier radiation oncology society in the world, with the mission of advancing the practice of radiation oncology.

Visit Website

Agenda

Oral presentation: 132

Title: Overcoming resistance to anti-PD-1 with tumor agnostic NBTXR3: from bench to bedside
Presenter: Tanguy Y. Seiwert, MD, PhD
Scientific Session Title: Bio 3 - Immunotherapy, Immune Response, and Inflammation
Poster viewing time: October 26 at 4:20 PM CDT / 11:20 PM CET
Click here to read the presentation

Poster presentation: 2805

Title: Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients
Presenter: Christophe Le Tourneau, MD, PhD
Track: Head and Neck Cancer
Poster viewing time: October 26 at 1:15 PM CDT / 8:15 PM CET
Click here to read the poster

Oral presentation: 77

Title: Study of novel radioenhancer NBTXR3 plus radiotherapy in patients with locally advanced soft tissue sarcoma: results of the long-term evaluation in the phase II/III Act.In.Sarc trial
Presenter: Sylvie Bonvalot, MD, PhD
Scientific Session Title: Sarcoma 1 - Individualization of Radiotherapy Based Treatment for Sarcoma and Cutaneous Malignancy
Poster viewing time: October 26 at 5:15 PM CDT / 12:15 AM CET
Click here to read the presentation

Poster presentation: 2865

Title: NBTXR3 Nanoparticle with ImmunoRadiation Might Reshape Metastatic Tumor-Infiltrating T Cell Repertoire in Murine Lung Cancer Model
Presenter:Chike O. Abana, MD, PhD
Scientific Session Title: Lung Cancer/Thoracic Malignancies and Palliative Care
Poster viewing time: October 26 3:30 PM CDT / 10:30 PM CET
Click here to read the poster

Poster presentation: 2739

Title: NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with advanced cancers: a phase I trial
Presenter: Colette Shen, MD, PhD
Track: Head and Neck Cancer
Poster viewing time: October 25 at 4:00 PM CDT / 11:00 PM CET
Click here to read the poster